Data from Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction

Abstract

<div>Abstract<p>Mounting clinical and preclinical evidence supports a key role for sustained adrenergic signaling in the tumor microenvironment as a driver of tumor growth and progression. However, the mechanisms by which adrenergic neurotransmitters are delivered to the tumor microenvironment are not well understood. Here we present evidence for a feed-forward loop whereby adrenergic signaling leads to increased tumoral innervation. In response to catecholamines, tumor cells produced brain-derived neurotrophic factor (BDNF) in an ADRB3/cAMP/Epac/JNK-dependent manner. Elevated BDNF levels in the tumor microenvironment increased innervation by signaling through host neurotrophic receptor tyrosine kinase 2 receptors. In patients with cancer, high tumor nerve counts were significantly associated with increased BDNF and norepinephrine levels and decreased overall survival. Collectively, these data describe a novel pathway for tumor innervation, with resultant biological and clinical implications.</p><p><b>Significance:</b> Sustained adrenergic signaling promotes tumor growth and metastasis through BDNF-mediated tumoral innervation. <i>Cancer Res; 78(12); 3233–42. ©2018 AACR</i>.</p></div>